Innovex International, Inc. (INVX)
NYSE: INVX · Real-Time Price · USD
28.54
+0.28 (0.99%)
Aug 27, 2026, 12:26 PM EDT - Market open
Innovex International Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 997.53 | 978.25 | 660.8 | 555.54 | 467.19 | 294.84 | |
Revenue Growth | 15.04% | 48.04% | 18.95% | 18.91% | 58.45% | - |
Cost of Revenue | 674.32 | 674.97 | 428.17 | 360.1 | 309.07 | 207.45 |
Gross Profit | 323.21 | 303.28 | 232.63 | 195.44 | 158.12 | 87.4 |
Selling, General & Admin | 148.45 | 128.79 | 116.18 | 72.8 | 59.19 | 50.78 |
Amortization of Goodwill & Intangibles | - | - | - | - | - | 5.32 |
Operating Expenses | 211.7 | 189.54 | 147.39 | 95.46 | 77.66 | 68.52 |
Operating Income | 111.51 | 113.75 | 85.24 | 99.98 | 80.46 | 18.88 |
Interest Expense | -1.33 | -2.58 | -2.43 | -5.51 | -4.03 | -2.16 |
Earnings From Equity Investments | - | - | 2.62 | 2.98 | - | - |
Other Non Operating Income (Expenses) | 2.34 | 1.83 | -0.3 | -0.39 | 1.12 | 3.52 |
EBT Excluding Unusual Items | 113.56 | 112.99 | 85.13 | 97.07 | 77.54 | 20.25 |
Merger & Restructuring Charges | -11.3 | -17.52 | -33.3 | -2.33 | -2.94 | -4.8 |
Gain (Loss) on Sale of Investments | - | - | 8.04 | - | - | - |
Gain (Loss) on Sale of Assets | 51.43 | 39.83 | 0.65 | -0.11 | -0.71 | -1.75 |
Asset Writedown | - | -3.43 | -3.52 | -0.27 | -0.96 | - |
Other Unusual Items | -3.34 | -3.34 | 85.81 | - | - | - |
Pretax Income | 98.74 | 128.53 | 142.81 | 94.37 | 72.93 | 13.7 |
Income Tax Expense | 37.19 | 45.23 | 2.49 | 20.44 | 9.65 | 3.84 |
Net Income | 61.56 | 83.3 | 140.33 | 73.93 | 63.28 | 9.85 |
Net Income to Common | 61.56 | 83.3 | 140.33 | 73.93 | 63.28 | 9.85 |
Net Income Growth | -57.39% | -40.64% | 89.82% | 16.83% | 542.22% | - |
Shares Outstanding (Basic) | 69 | 69 | 50 | 31 | 31 | 15 |
Shares Outstanding (Diluted) | 70 | 69 | 51 | 32 | 31 | 15 |
Shares Change | 0.55% | 37.04% | 56.55% | 2.85% | 115.52% | - |
EPS (Basic) | 0.89 | 1.21 | 2.82 | 2.39 | 2.07 | 0.68 |
EPS (Diluted) | 0.89 | 1.20 | 2.77 | 2.29 | 2.01 | 0.68 |
EPS Growth | -57.38% | -56.68% | 20.96% | 13.93% | 197.63% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 124.23 | 155.78 | 79.85 | 60.38 | -15.39 | -8.47 |
Free Cash Flow Per Share | 1.79 | 2.25 | 1.58 | 1.87 | -0.49 | -0.58 |
Gross Margin | 32.40% | 31.00% | 35.20% | 35.18% | 33.84% | 29.64% |
Operating Margin | 11.18% | 11.63% | 12.90% | 18.00% | 17.22% | 6.40% |
Profit Margin | 6.17% | 8.52% | 21.24% | 13.31% | 13.54% | 3.34% |
Free Cash Flow Margin | 12.45% | 15.92% | 12.08% | 10.87% | -3.29% | -2.87% |
EBITDA | 174.77 | 174.49 | 116.45 | 122.64 | 98.92 | 36.61 |
EBITDA Margin | 17.52% | 17.84% | 17.62% | 22.08% | 21.17% | 12.42% |
D&A For EBITDA | 63.26 | 60.74 | 31.21 | 22.66 | 18.47 | 17.74 |
EBIT | 111.51 | 113.75 | 85.24 | 99.98 | 80.46 | 18.88 |
EBIT Margin | 11.18% | 11.63% | 12.90% | 18.00% | 17.22% | 6.40% |
Effective Tax Rate | 37.66% | 35.19% | 1.74% | 21.66% | 13.23% | 28.05% |
Revenue as Reported | 997.53 | 978.25 | 660.8 | 555.54 | 467.19 | - |